Structure-based classification of EGFR mutations informs inhibitor selection for lung cancer therapy. Yenerall P, Kittler R, Minna J. Cancer Cell 2021;39:1455-1457.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yenerall P, Kittler R, Minna J. Structure-based classification of EGFR mutations informs inhibitor selection for lung cancer therapy. Cancer Cell 2021;39:1455-1457.
PMID: 34752753